Accueil/Actions/KMDA

KMDA

USD

Kamada Ltd. Ordinary Shares

$6.950+0.000 (0.000%)

Prix en Temps Réel

Healthcare

Drug Manufacturers - Specialty & Generic

Israël

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$6.950

Haut

$7.090

Bas

$6.930

Volume

0.06M

Fondamentaux de l'Entreprise

Capitalisation Boursière

403.0M

Industrie

Drug Manufacturers - Specialty & Generic

Pays

Israel

Statistiques de Trading

Volume Moyen

0.09M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $4.74Actuel $6.950Haut $9.15

Actualités Connexes

15 mai 2025 · 14:39

Analyst Upgrades

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

Benchmark analyst Robert Wasserman reiterates Kamada with a Buy and maintains $15 price target.

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

7 mai 2025 · 11:00

GlobeNewswire

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

5 mai 2025 · 11:00

GlobeNewswire

Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ TransplantationA Total of 10 Studies will be Conducted in Collaboration with